Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-011179

Chief Executive Officer gave up 1,176 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ciechanover Isaac E. Chief Executive Officer 2019-02-15 Shares withheld for taxes −1,176 $40.45 $47,569 332,243 D
Loading xslF345X03/doc4.xml…